Literature DB >> 22374672

MDM4 enhances p53 stability by promoting an active conformation of the protein upon DNA damage.

Giusy Di Conza1, Francesca Mancini, Marianna Buttarelli, Alfredo Pontecorvi, Francesco Trimarchi, Fabiola Moretti.   

Abstract

Stabilization of p53 protein is an important step in the activation of its function. p53 levels are regulated by ubiquitin-dependent and -independent degradation pathways. MDM4 (MDMX) is an important regulator of p53, able to both stimulate and antagonize p53 degradation. Both of these activities have been attributed to the ability of MDM4 to potentiate or antagonize the function of MDM2, the main ubiquitin ligase of p53, depending on their relative levels. Here, we have investigated the stabilizing function of endogenous MDM4 using genetic models of knockout MEFs and RNA interference in human non-transformed cell lines. Our data demonstrate that MDM4 is able to stabilize p53, protecting it from proteasome-mediated degradation in a MDM2- and ubiquitin-independent manner. Upon DNA damage, MDM4 is associated to p53 independently of MDM2 and promotes a conformational change of the protein toward an active form. This correlates with a decreased association of p53 to the proteasome and increased protein levels. The association between MDM4 and p53 is evidenced in the cytoplasmic compartment, supporting the role of cytoplasmic stabilization of p53 during its activation. This work demonstrates that the ability of MDM4 to enhance p53 stability is actually a specific property of MDM4 accomplished upon DNA damage. In addition, these data support the hypothesis of distinct functions of MDM4 under different growth conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22374672     DOI: 10.4161/cc.11.4.19208

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  9 in total

1.  Novel insights about the MDM2/MDM4 heterodimer.

Authors:  Fabiola Moretti
Journal:  Mol Cell Oncol       Date:  2015-08-20

2.  p53 Regulation Goes Live-Mdm2 and MdmX Co-Star: Lessons Learned from Mouse Modeling.

Authors:  Laura A Tollini; Yanping Zhang
Journal:  Genes Cancer       Date:  2012-03

Review 3.  The Roles of MDM2 and MDMX in Cancer.

Authors:  Orit Karni-Schmidt; Maria Lokshin; Carol Prives
Journal:  Annu Rev Pathol       Date:  2016-03-17       Impact factor: 23.472

4.  High Mdm4 levels suppress p53 activity and enhance its half-life in acute myeloid leukaemia.

Authors:  Ban Xiong Tan; Kian Hoe Khoo; Tit Meng Lim; David Philip Lane
Journal:  Oncotarget       Date:  2014-02-28

Review 5.  Regulation of the DNA damage response by ubiquitin conjugation.

Authors:  Kerstin Brinkmann; Michael Schell; Thorsten Hoppe; Hamid Kashkar
Journal:  Front Genet       Date:  2015-03-10       Impact factor: 4.599

6.  MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.

Authors:  F Mancini; L Pieroni; V Monteleone; R Lucà; L Fici; E Luca; A Urbani; S Xiong; S Soddu; R Masetti; G Lozano; A Pontecorvi; F Moretti
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

7.  Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic properties.

Authors:  Rossella Lucà; Maria Rita Assenza; Fabio Maiullari; Luisa Pieroni; Silvia Maiullari; Giulia Federici; Federica Marini; Roberto Rizzi; Andrea Urbani; Silvia Soddu; Fabiola Moretti
Journal:  Cell Death Dis       Date:  2021-05-29       Impact factor: 8.469

8.  MDM2-MDM4 molecular interaction investigated by atomic force spectroscopy and surface plasmon resonance.

Authors:  Ilaria Moscetti; Emanuela Teveroni; Fabiola Moretti; Anna Rita Bizzarri; Salvatore Cannistraro
Journal:  Int J Nanomedicine       Date:  2016-08-30

9.  Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4.

Authors:  Rossella Lucà; Giorgia di Blasio; Daniela Gallo; Valentina Monteleone; Isabella Manni; Laura Fici; Marianna Buttarelli; Germana Ciolli; Marsha Pellegrino; Emanuela Teveroni; Silvia Maiullari; Alessandra Ciucci; Alessandro Apollo; Francesca Mancini; Maria Pia Gentileschi; Gian Franco Zannoni; Alfredo Pontecorvi; Giovanni Scambia; Fabiola Moretti
Journal:  Cancers (Basel)       Date:  2019-09-12       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.